Evonik Industries (ETR:EVK) target price increased to 30.00EUR, issued a research note today by Baader Wertpapierhandelsbank
- Updated: October 14, 2016
Stating a potential upside of 0.02%, Baader Wertpapierhandelsbank upped the target price of Evonik Industries (ETR:EVK) to 30.00EUR
On Friday October 14, 2016, Baader Wertpapierhandelsbank released a statement on Evonik Industries (ETR:EVK) bumped up the target price from 0.00EUR to 30.00EUR. At the time, this indicated a possible upside of 0.02%.
Having a price of 29.53EUR, Evonik Industries (ETR:EVK) traded 4.35% higher on the day. With the last stock price close up 14.08% from the 200-day moving average, compared to the S&P 500 which has decreased -0.01% over the same time period. EVK has recorded a 50-day moving average of 2.32EUR and a 200-day moving average of 2.10EUR. 500 shares of the stock were exchanged, down from an avg. volume of 6,902
Recent Performance Chart
Evonik Industries has price-earnings ratio of 3.44 with a 52 week low of 1.35EUR and a 52 week high of 3.09EUR and has a market cap of 0 EUR.
About Evonik Industries (ETR:EVK)
Evonik Industries AG (Evonik) is a Germany-based company engaged in the specialty chemicals sector. The Company's activities are divided in four segments: Nutrition & Care, produces specialty chemicals, mainly for use in consumer goods for daily needs and food, as well as in animal nutrition and healthcare products; Resource Efficiency, offers material solutions for environment-friendly and energy-efficient products used in the automotive, adhesives and construction industries, among others; Performance Materials, produces polymer materials and their intermediates, mainly for the rubber, plastics and agriculture sectors, and Services, includes site management, utilities and waste management, as well as technical, process technology, engineering and logistics services for the chemicals segments and external customers at Company's sites, among others. It is a subsidiary of RAG Stiftung.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.